January 10, 2011
CASE CCC IN THE NEWS
Communication Important When Facing Complex Medical Decisions
Damon Runyon Cancer Research Foundation Clinical Investigator Award
CWRU SOM has been invited to nominate up to three individuals for the Damon Runyon Cancer Research Foundation Clinical Investigator Award. This award supports young physician-scientists conducting patient-oriented cancer research, with a goal of increasing the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments.
New this year is a novel partnership with the National Institutes of Health (NIH) and the National Cancer Institute (NCI), which opens access to the NIH Clinical Center (CC) to Damon Runyon Clinical Investigators. The goal of this partnership is to use the special talent, expertise and resources of the participants to undertake pilot studies of specific diseases and to develop collaborative partnerships that accelerate clinical and translational cancer research, and thereby improve human health. See the website for more information.
If you are interested in applying for this award, please submit the following materials to email@example.com by TODAY, Monday, January 10: biosketch and a one-paragraph description of how your research fits the description of "Clinical Research" as described by the Damon Runyon Foundation.
Internal Deadline: TODAY, January 10
Interinstitutional Basic, Clinical and Translational Research Projects in Cancer
The Case CCC will provide seed money to foster collaborations and promote and increase institution-wide capacity and competitiveness in basic, clinical or translational research that is aligned with the Cancer Center Scientific Programs and spans the institutions of the Case CCC. 2-3 awards of $75,000 - $100,000 will be made.
Faculty at all levels with interests in cancer research are encouraged to apply. Proposals require a minimum of two PIs: one from Case/UH and one from Cleveland Clinic. Proposals must involve new collaborative work with no joint publications or grants related to the current project. Applications will be submitted through http://webgrants.case.edu.
Deadline: January 18, 2011
Complete information is available on the Cancer Center website.
New cancer research protocols requiring IRB review will be submitted, reviewed and stored electronically using the Case Cancer IRB electronic, web-based submission and review database provided by iMedRIS™ Data Corporation.
Part 4 (How to Respond to Stipulations) and Part 5 (How to submit Amendments) of the iMedRIS™ training sessions will be offered January through February. All interactive training will be accessible online using Adobe Acrobat Connect and telephone conference line and can be accessed at personal workstations.
Shared Instrumentation Grant - DEXA Scanner
Message from Dr. Nathan Berger
As part of the Case CCC, we anticipate responding to NIH Shared Instrument Grant (S1O) PAR-11-081 with a request for a Dual-Energy X-ray Absorption (DEXA) Scanner. DEXA Scanning provides state-of-the-art technology for measurement of lean body-muscle mass, fat mass and bone density. We will apply for a patient level instrument and if enough interest exists, we will also apply for an instrument to perform the same measurements in small animals. Policy permitting, we are also considering applying for a Direct Segmental Multi-Frequency Bioelectrical Impedance Apparatus to perform repetitive measurements of body composition.
As you know, these awards are made to support the needs of groups of NIH funded investigators. Accordingly, I am requesting that any NIH funded investigators who anticipate using DEXA Scanning as a research tool notify me of their intent and send to me by January 20 a description of their research and need for these measurements (no more than 1 page), along with name, title and description of relevant NIH grant funding and an updated copy of your biosketch in NIH format. Please send all materials to firstname.lastname@example.org.
Please pass this email along to any other faculty member who might be interested. I would be happy to talk to anyone who wants further clarification.
Clinical Assay Development Program (CADP)
The NIH has recently unveiled a new program, the Clinical Assay Development Program (CADP), designed to provide support and expertise to aid in the transition of predictive or prognostic cancer research assays to clinically validated, robust, "CLIA-approved" assays. This program is similar in scope and design to the RAID program for drug development.
The assay to be developed must measure predictive or prognostic markers, assays measuring diagnostic markers will not be considered for this program. The primary biospecimens to be utilized will be archived, formalin fixed, paraffin embedded tissues, however, assays utilizing other biospecimens will be acceptable if they are sufficiently compelling. One important eligibility criterion requires that the assay must be able to be performed with instrumentation and techniques available in standard clinical labs.
The deadline for the first round of applications is January 21.
For additional information or to request assistance in development of an application, please contact: John Pink (email@example.com), Director, Translational Research Core Facility, Case Comprehensive Cancer Center.
MARK YOUR CALENDARS
14th Annual Meeting of the Translational Research Cancer Centers Consortium 2011
The 14th Annual Meeting of the Translational Research Cancer Centers Consortium 2011 to be held at Seven Springs Mountain Resort, Seven Springs, PA on February 24-26. The goal of the conference is to gain a greater understanding of the interactions between the immune system and cancer in the setting of biologic therapy of cancer. This meeting is dedicated to the review of the newly-available biological agents and modes of their application, greater understanding of the modes of their action, potential for their synergistic and antagonistic effects, and the development of the optimal strategies for their clinical evaluation and eventual implementation as an integral part of comprehensive cancer care.
Planning committee members include Drs. Joseph Baar, Gregory Plautz, and Pierre Triozzi.
ISSCR 9th Annual Meeting
Registration is open for the International Society for Stem Cell Research (ISSCR) Annual Meeting, June 15-18 in Toronto, Canada. The ISSCR Annual Meeting has become the preeminent international stem cell meeting of the foremost stem cell professionals from public, private, academic and government settings. It provides a forum to promote and foster the exchange of research, featuring leading discoveries of the year and serving as a catalyst for stem cell research around the world.
Abstracts will be accepted through February 8. Abstract submission topics are available on the event website. Posters will be on display for the duration of the meeting.
**All events are open to anyone interested in attending
Physiology and Biophysics Seminar
Cancer Imaging Nanotechnology Subgroup Meeting
CCF / UH Urology Meeting
Cancer Biology Fellow Seminar
Taussig Cancer Institute Core Curriculum Series
Hematology and Oncology Division Research Conference canceled
Immunology Visiting Professor Seminar Series
DNA Repair Inhibition Journal Club
Taussig Cancer Institute Core Curriculum Series
Tumor Microenvironment and Metastasis Focus Group Meeting
Hematology/Oncology Special Conference
Taussig Cancer Institute Grand Rounds
Cancer Center Seminar Series
Cell Biology Seminar Series
Cancer Center Research in Progress Seminar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Breast Health Update: Issues for 2011
8th International Conference of the Society for Integrative Oncology
ADDITIONAL UPCOMING SEMINARS & EVENTS
Active Living Research Annual Conference
Multilevel Interventions in Health Care: Building the Foundation for Future Research Goals
4th Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science
2011 Clinical and Translational Research and Education Meeting: ACRT/SCTS Joint Annual Meeting
Cancer Health Disparities Summit 2011
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
Prostate Cancer Foundation (PCF) 2011 Creativity Awards
Leukemia Research Foundation
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.